ANL 15.49 Decreased By ▼ -0.71 (-4.38%)
ASC 14.00 Decreased By ▼ -0.63 (-4.31%)
ASL 20.00 Decreased By ▼ -0.04 (-0.2%)
BOP 8.70 Increased By ▲ 0.15 (1.75%)
BYCO 7.30 Decreased By ▼ -0.23 (-3.05%)
FCCL 16.98 Decreased By ▼ -0.52 (-2.97%)
FFBL 22.80 Decreased By ▼ -0.35 (-1.51%)
FFL 14.90 Decreased By ▼ -0.35 (-2.3%)
FNEL 7.06 Decreased By ▼ -0.29 (-3.95%)
GGGL 16.30 Decreased By ▼ -0.85 (-4.96%)
GGL 28.40 Decreased By ▼ -1.55 (-5.18%)
HUMNL 6.14 Increased By ▲ 0.18 (3.02%)
JSCL 20.40 Decreased By ▼ -0.28 (-1.35%)
KAPCO 28.50 Decreased By ▼ -0.49 (-1.69%)
KEL 3.41 Decreased By ▼ -0.07 (-2.01%)
MDTL 2.15 Increased By ▲ 0.04 (1.9%)
MLCF 32.48 Decreased By ▼ -1.12 (-3.33%)
NETSOL 101.45 Decreased By ▼ -4.55 (-4.29%)
PACE 4.20 Decreased By ▼ -0.13 (-3%)
PAEL 26.51 Decreased By ▼ -1.44 (-5.15%)
PIBTL 8.40 Decreased By ▼ -0.30 (-3.45%)
POWER 6.71 Decreased By ▼ -0.19 (-2.75%)
PRL 16.38 Decreased By ▼ -0.80 (-4.66%)
PTC 9.11 Decreased By ▼ -0.19 (-2.04%)
SILK 1.42 Decreased By ▼ -0.02 (-1.39%)
SNGP 42.50 Increased By ▲ 0.17 (0.4%)
TELE 16.45 No Change ▼ 0.00 (0%)
TRG 128.35 Decreased By ▼ -7.43 (-5.47%)
UNITY 28.69 Decreased By ▼ -1.21 (-4.05%)
WTL 2.28 Decreased By ▼ -0.12 (-5%)
BR100 4,607 Decreased By ▼ -60.66 (-1.3%)
BR30 20,274 Decreased By ▼ -617.96 (-2.96%)
KSE100 44,629 Decreased By ▼ -192.08 (-0.43%)
KSE30 17,456 Decreased By ▼ -65.93 (-0.38%)

Coronavirus
LOW Source: covid.gov.pk
Pakistan Deaths
28,300
2024hr
Pakistan Cases
1,265,650
60324hr
1.38% positivity
Sindh
466,154
Punjab
438,133
Balochistan
33,133
Islamabad
106,504
KPK
176,950
World

Germany to give different second jab to AstraZeneca recipients under 60

  • Most of the cases reported were in women under 60 years of age within two weeks of vaccination.
14 Apr 2021

BERLIN: People aged under 60 who have been given a first dose of the Oxford-AstraZeneca coronavirus vaccine in Germany will receive a different jab for their second dose, federal and regional health ministers agreed Tuesday.

Germany announced on March 30 that it would no longer offer the two-dose AstraZeneca vaccine to people aged under 60 due to concerns over a possible link to rare cases of blood clots.

DPA news agency said ministers agreed at a meeting that people in the younger age group who received a first AstraZeneca dose before the March 30 announcement will be offered either the BioNTech-Pfizer jab for their second dose, or the Moderna vaccine.

"The solution that has been found will offer a good level of protection," Bavarian Health Minister Klaus Holetschek told DPA.

The new policy is in line with recommendations released last week by Germany's vaccine commission, which also recommended the second injection be given 12 weeks after the initial AstraZeneca dose.

Germany is among numerous countries that have restricted use of the AstraZeneca vaccine to older people after rare blood clots were detected in a small number of younger people who had received the jab.

The European Medicines Agency last week said that unusual blood clots should be listed as a very rare side effect of the AstraZeneca vaccine, while stressing that overall benefits in preventing Covid-19 outweighed the risks.

There were 222 cases of these atypical thromboses out of 34 million AstraZeneca injections carried out in the European Economic Area (EU, Iceland, Norway, Liechtenstein) and Britain, as of April 4, according to the EMA. And there were 18 deaths, as of March 22.

Most of the cases reported were in women under 60 years of age within two weeks of vaccination.

According to Germany's health ministry some 2.2 million people aged under 60 have received an AstraZeneca dose in recent weeks.

Johnson & Johnson's single-shot vaccine has come under similar suspicion for the same issue, with US health authorities recommending Tuesday that it be paused while they investigate six cases of clotting.

The World Health Organization has said it cannot recommend switching vaccine between two doses as a protection against Covid-19, due to insufficient data showing the effects.

Comments

Comments are closed.